This social medical institution collaborates with enterprises to incubate a digital chronic disease management platform, providing medical services for over 300 million cardiovascular disease patients in China
Today, the first medical innovation service summit forum held by Yaoying Medical Group reported that the number of cardiovascular disease patients in China has exceeded 300 million. In the past 10 years, the number of diabetes patients has increased from 90 million to 140 million. At present, one fourth of Chinese adults have hypertension, and the overall prevalence rate of adult dyslipidemia is 40%. The increase of cholesterol level in the population will also lead to an increase in cerebral infarction or myocardial infarction. Experts attending the meeting stated that a new model is needed for chronic disease management to enhance patient compliance and achieve timely and effective intervention.
The incidence of chronic diseases in our country is becoming younger, and disease management is not only related to personal and family well-being, but also involves social public health services. As long as chronic diseases are well controlled, the associated risks will significantly decrease. Dr. Shi Haoying, founder and CEO of Yaoying Medical, provides an example: for every 1mmol/l decrease in low-density lipoprotein cholesterol, the risk of cardiovascular and cerebrovascular events decreases by 22% over 5 years; For every decrease of 2mmol/l, the risk of cardiovascular and cerebrovascular events decreases by 39% over 5 years.
A research survey of large foreign enterprises shows that the investment ratio of proactive health management in the workplace is 1:6, which means that for every $1 invested in employee health, the cost of employee dependency decreases by $3.27, and the cost of absenteeism rate decreases by $2.73.
How to manage chronic diseases, the current patient population and most enterprises are not professional. As one of the representatives of social medical institutions in Shanghai, Yaoying Medical has joined hands with enterprises to increase research and development, integrate high-quality medical technology, clinical experience, digital technology, and wearable devices, and incubate digital chronic disease management products.
The reporter learned that this platform incubated through cooperation between medical enterprises can provide patients with wearable devices such as electronic blood pressure monitors and dynamic blood glucose monitors for different chronic diseases, or connect to mainstream brand sports watches. By continuously reading corresponding clinical data over a long period of time, combined with the patient's offline medical history, backend data analysis can be formed. Through the intervention of a multidisciplinary medical team, real-time monitoring of the condition, provision of disease progression warnings, drug efficacy analysis, lifestyle support, and smooth offline visits can be achieved.
It is reported that the hospital has formed a multidisciplinary team with general practitioners, endocrinologists, and cardiologists as the core, covering health managers, specialists, and nutritionists. Expert supplement: The exploration of a new management model aims to integrate medical resources around "clinical data to medical decision-making", create "upgraded" chronic disease management services for families in need, and provide workplace health management for large enterprises through customized cooperation models, significantly reducing enterprise health management costs.
As a social medical institution founded by doctors, Yaoying Medical has been building a medical network with one hospital and eight outpatient departments since 2016. At the forum, it also collaborated with the well-known international third-party medical insurance management service company MSH CHINA, Wanxinhe, to launch strategic cooperation, aiming to provide diversified health services to more people.
